company logo

Dublin, April 05, 2022 (GLOBE NEWSWIRE) — The Cell Culture Global Market Report 2022: By Type, By Media, By Applications has been added to from offer.

This report provides strategists, marketers, and senior management with the essential information they need to assess the global cell culture market.

This report focuses on the cell culture market which is experiencing high growth. The report gives a guide to the cell culture market that will shape and change our lives over the next ten years and beyond, including the market response to the challenge of the global pandemic.

Reasons to buy

  • Gain a truly global perspective with the most comprehensive market report available covering over 12 geographies

  • Understand how the market is affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus diminishes

  • Create regional and national strategies based on local data and analysis

  • Identify growth segments for investment

  • Outperform your competition using forecast data and the drivers and trends shaping the market

  • Understand customers based on the latest market research

  • Benchmark performance against leading competitors

  • Use relationships between key data sets for better strategy

  • Suitable to support your internal and external presentations with reliable high quality data and analysis

The major players in the cell culture market are Thermo Fisher Scientific Inc., Corning, Inc., Becton, Dickinson and Company, Eppendorf AG, Merck KGAA, Lonza Group AG, Sartorius AG, Promocell GmbH, Danaher, and Sartorius.

The global cell culture market is expected to grow from $20.28 billion in 2021 to $22.49 billion in 2022 at a compound annual growth rate (CAGR) of 10.9%. The growth is primarily due to businesses resuming operations and adjusting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing, remote work and the closure of business activities that have resulted in operational challenges. The market is expected to reach $34.01 billion in 2026 at a CAGR of 10.9%.

The cell culture market includes sales of cell culture equipment and consumables for drug development and related services. Cell culture is the process by which cells are grown in appropriate sterile environments under controlled conditions. Cell culture is one of the primary tools used in molecular and cellular biology, drug manufacturing, and large-scale manufacturing of biological compounds.

The main types of cell culture are primary cell culture, secondary cell culture, and cell line. Primary cell cultures are those that develop from tissue explants or specific cells extracted from the source tissue. The different media include natural, artificial, and are used in stem cell technologies, cancer research, biopharmaceuticals, tissue engineering, and regenerative medicine, etc.

North America was the largest cell culture market region in 2021. The Middle East is expected to be the fastest growing region during the forecast period. Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Rising demand for cell therapy is expected to drive the cell culture market. In cell therapy, viable cells are injected or implanted into a patient’s body to cure a medicinal disease. Cell culture is an essential step in any cell therapy. According to the Cancer Research Institute (CRI), there are approximately 1,483 active cell therapies in development in 2020 compared to 1,011 in 2019. Cell culture is used in the development, manufacturing and commercialization of cell therapies and has the potential to revolutionizing the health care industry for the treatment of various diseases. Hence, an increase in the demand for cell therapy is contributing to the growth of the cell culture market.

Lack of skilled professionals is expected to hamper the cell culture market growth. The consequence of having unskilled workers can also be detrimental to a company’s bottom line, as even a small batch mistake can cost an organization millions of dollars. The regulatory body that licenses the facility requires an annual report that includes all failed batches, and if the failure rate is greater than 5%, the facility risks losing the ability to sell its drug. Furthermore, according to a skills survey carried out by the Cell and Gene Therapy Catapult (CGTC) in 2019, UK cell and gene therapy companies are concerned about the shortage of qualified manufacturing personnel for the expansion of their business. Lack of talent is expected to negatively impact the growth of cell and gene therapy industry, thereby restraining the growth of cell culture market.

The development of products for 3D cell culture by companies operating in the cell culture market is gaining popularity. A 3D cell culture is an artificially created environment in which biological cells are allowed to grow or interact with their surroundings in all three dimensions, just as they would in a living organism. For example, in July 2020, Rigenerand, an Italian company engaged in the production of innovative cell-based technology products for regenerative medicine and oncology, launched a 3D bioreactor called VITVO portable bioreactor to provide ease of use, increased sizing, closed system and flexibility. for 3D cell culture technologies. Similarly, Jellagen, a UK-based marine biotechnology company, has launched JellaGel, a jellyfish collagen hydrogel, suitable for 3D cell culture and tissue engineering.

In March 2020, Danaher, a US-based Fortune 500 science and technology company, acquired the biopharmaceutical business of General Electric Life Sciences for $21.4 billion. Part of Danaher, the company will be called Cytiva and will be a stand-alone operating company within Danaher’s Life Sciences segment. GE Biopharma’s offerings included cell culture media, single-use technologies, process chromatography equipment and consumables, development instruments and consumables, and services.

The countries covered in the Cell Culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the United Kingdom and the United States.

Main topics covered:

1. Summary

2. Characteristics of Cell Culture Market

3. Cell Culture Market Trends and Strategies

4. Impact of COVID-19 on cell culture

5. Cell Culture Market Size and Growth
5.1. Global Cell Culture Historic Market, 2016-2021, USD Billion
5.1.1. Market Drivers
5.1.2. Market Constraints
5.2. Global Cell Culture Forecast Market, 2021-2026F, 2031F, Billion USD
5.2.1. Market Drivers
5.2.2. Market Constraints

6. Cell Culture Market Segmentation
6.1. Global Cell Culture Market, Segmentation by Type, History and Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Primary cell culture

  • Secondary cell culture

  • Cell line

6.2. Global Cell Culture Market, Segmentation by Media, History and Forecast, 2016-2021, 2021-2026F, 2031F, Billion USD

6.3. Global Cell Culture Market, Segmentation by Application, History and Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

7. Regional and Country Analysis of Cell Culture Market
7.1. Global Cell Culture Market, Split by Region, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion
7.2. Global Cell Culture Market, Split by Country, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900